Med. praxi. 2020;17(3):197-199
Smokers' adherence to ischeamic heart disease prevention
- Centrum pro závislé na tabáku III. interní kliniky 1. LF UK a VFN, Praha
- Ústav hygieny a epidemiologie 1. LF UK a VFN, Praha
In general, smokers tend to have lower adherence to treatment, including any medication intake and prevention, as well - in the case of coronary artery disease (CAD), this is primarily due to poorer diet, such as more fat, and less physical activity. However, smoking is also associated with a higher incidence of many other cardiovascular risk factors (CV RF) such as diabetes mellitus, abdominal fat deposition or depression. Although weight can increase after quitting smoking, the CV risk is clearly reduced by about a half.
Keywords: smoking cardiovascular risk, prevention, adherence.
Published: June 18, 2020 Show citation
References
- SCORE algoritmus pro výpočet desetileté pravděpodobnosti fatální kardiovaskulární příhody založený na Weibullově modelu [online]. Dostupné z: https://www.ikem.cz/cs/score-algoritmus-pro-vypocet-desetilete-pravdepodobnosti-fatalni-kardiovaskularni-prihody-zalozeny-na-weibullove-modelu/a-2177/.
- Anthony D, George P, Eaton CB. Cardiac risk factors: environmental, sociodemographic, and behavioral cardiovascular risk factors. FP Essent. 2014; 421: 16-20.
- Montoya ID, Herbeck DM, Svikis DS, Pincus HA. Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice. Am JAddict. 2005; 14(5): 441-454.
Go to original source... - Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120: 1598-1605. Go to original source...
- Ludka O. Motivace pacienta k celoživotnímu užívání léků u arteriální hypertenze. Med. praxi 2017; 14(1): 11-14. Go to original source...
- Zvolská K, Králíková E. Centra pro závislé na tabáku v ČR v roce 2016. Čas Lék Čes 2017; 156(1): 19-23.
- Kleinsinger F. Working with the Noncompliant Patient. Perm J. 2010 Spring; 14(1): 54-60. Go to original source...
- Basu S, Garg S, Sharma N, Singh MM. Improving the assessment of medication adherence: Challenges and considerations with a focus on low-resource settings. Ci Ji Yi Xue Za Zhi. 2019; 31(2): 73-80. Go to original source...
- Hu Y, Zong G, Liu G, et al. Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality. N Engl J Med. 2018; 379(7): 623-632. Go to original source...
- Virdis A, Giannarelli C, Neves MF, Taddei S, Ghiadoni L. Cigarette smoking and hypertension. Curr Pharm Des. 2010; 16(23): 2518-2525. Go to original source...
- Heggen E, Svendsen M, Tonstad S. Smoking cessation improves cardiometabolic risk in overweight and obese subjects treated with varenicline and dietary counseling. Nutr Metab Cardiovasc Dis. 2017; 27(4): 335-341. Go to original source...
- Tonstad S. Weight gain does not attenuate cardiovascular benefits of smoking cessation. Evid Based Med. 2014; 19(1): 25. Go to original source...
Go to PubMed... - Stepankova L, Kralikova E, Zvolska K, et al. Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up. Ann Behav Med. 2017; 51(3): 454-463. Go to original source...
- Csémy L, Fialová A, Kodl M, Skývová M. Užívání tabáku a alkoholu v České republice 2018. SZÚ, 2019 [online]. Dostupné z: http://www.szu.cz/uploads/documents/szu/aktual/uzivani_tabaku_alkoholu_cr_2018.pdf.
- Nechanská B, Mravčík V, Sopko B, Velebil P. Rodičky užívající alkohol, tabák a nelegální drogy, Česká gynekologie, 2012; 77(5): 457-469. Go to PubMed...